RHINISENG®: Field efficacy

Trang chủ Tri thức RHINISENG®: Field efficacy

RHINISENG®: Field efficacy

RHINISENG® is a vaccine against progressive (PAR) and nonprogressive atrophic rhinitis (NPAR) indicated for pregnant sows and gilts to passively protect their offspring. The RHINISENG® recommended vaccination scheme includes a basic vaccination scheme (vaccination 8-6 weeks before farrowing and revaccination 4-3 weeks before farrowing) and a booster dose (4-3 weeks before the subsequent farrowing). This study evaluated the vaccine field efficacy of the basic vaccination scheme and the booster dose.

Giới thiệu về bài báo này

Tác giả

Montané, J.; Noguera, M.; Monells, M.; Ruiz, M.C.; Roca, M.; Camprodon, A.; March, R.; Sitjà, M.

Tóm tắt

RHINISENG® significantly reduced the atrophic rhinitis lesions until the end of the fattening period (Figure 1) in actively infected pigs and also reduced the slaughter age (Figure 3). A significant seroconversion to PMT and Bb was induced in actively immunised sows, both after applying the RHINISENG® basic vaccination scheme and after boosting during the subsequent gestation (Figure 2). These antibodies were effectively transferred via colostrum to protect their offspring.

Dịch vụ liên quan

Sản phẩm liên quan

Chia sẻ